Smith & Nephew

Smith & Nephew is an industry leader in each of our three main Global Business Units - Orthopaedic Reconstruction and Trauma, Endoscopy and Advanced Wound Management. These businesses jointly offer over 1,000 product ranges.

Our global infrastructure continues to expand each year. We currently operate in 32 countries and generate annual sales of $3.4 billion. Substantial investment in our products and intensive research and development means that we are always ahead. Figures from last year show that we stand at number one as the leading company in Arthroscopy. We are the second largest organisation in Advanced Wound Management and number three in Trauma and Clinical Therapies. We are also positioned at number four in reconstruction.

Smith & Nephew has a track record of bringing innovative new products to market that provide better clinical outcomes for patients and save costs for healthcare providers. This is the primary focus of our fourth business unit, Biologics.

Company Growth (employees)
London, GB
Size (employees)
15,584 (est)+7%
Smith & Nephew was founded in 1856 and is headquartered in London, GB

Key People at Smith & Nephew

Olivier Bohuon

Olivier Bohuon

Graham Baker

Graham Baker

John W. Campo

John W. Campo

Helen Maye

Helen Maye

Philippe Mazas

Philippe Mazas

Group CIO

Smith & Nephew Office Locations

Smith & Nephew has offices in London, São Paulo, Andover, Memphis and in 19 other locations
London, GB (HQ)
15 Adam Street
Horsholm, DK
Slotsmarken 14
Durham, US
4721 Emperor Blvd. Suite 100
Fort Worth, US
3909 Hulen Street
Austin, US
7000 W William Cannon Dr.
St. Petersburg, US
970 Lake Carillon Drive Suite 110
Memphis, US
1450 Brooks Road
Andover, US
150 Minuteman Road
São Paulo, BR
Av. do Café, 277

Smith & Nephew Metrics

Smith & Nephew Financial Metrics

Market capitalization (21-Mar-2017)

$568.3 m

Closing share price (21-Mar-2017)


Cash (31-Dec-2015)

£82.4 m
Smith & Nephew's current market capitalization is $568.3 m.
Smith & Nephew's revenue was reported to be £3.2 b in FY, 2015 which is a 0.4% increase from the previous period.
FY, 2013FY, 2014FY, 2015


£2.9 b£3.2 b£3.2 b

Revenue growth, %


Cost of goods sold

£724.8 m£797.5 m£784.4 m

Gross profit

£2.1 b£2.4 b£2.4 b

Gross profit Margin, %


Operating expense total

£1.6 b£1.9 b£2 b

Pre tax profit

£528.4 m£490 m£383.6 m

Net Income

£366.3 m£343.8 m£281.4 m
FY, 2013FY, 2014FY, 2015


£90.3 m£63.8 m£82.4 m

Accounts Receivable

£616.1 m£664.3 m£644.4 m

Current Assets

£1.5 b£1.7 b£1.7 b


£825.6 m£749.4 m£808.5 m


£1.5 b£2.6 b£2.4 b

Total Assets

£3.8 b£5 b£4.9 b

Accounts Payable

£494.8 m£553.8 m£554.5 m

Current Liabilities

£707 m£797.5 m£922.4 m

Retained Earnings

£208.9 m£179.8 m£94.7 m

Total Equity

£2.7 b£2.8 b£2.7 b

Financial Leverage

1.4 x1.8 x1.8 x
FY, 2013FY, 2014FY, 2015

Cash From Operating Activities

£571.3 m£468.7 m£706.9 m

Cash From Financing Activities

(£328.1 m)£691.8 m(£383 m)

Income Taxes Paid

(£162.1 m)(£146.2 m)(£102.3 m)

Smith & Nephew Operating Metrics

Smith & Nephew's Training Provided, no. of people was reported to be 90 k in FY, 2016
FY, 2016

Training Provided, no. of people

90 k

Smith & Nephew Market Value History

Smith & Nephew Revenue Breakdown

Smith & Nephew Median Salaries

Source: 81 public H-1B filings from Smith & Nephew

Smith & Nephew Online Presence

Smith & Nephew News

Smith & Nephew Company Life

You may also be interested in